Hypolipidemic Agents: all 738 studies that test it

Page 5 of 8. Open to participants first (69), then studies with results posted, then the rest; newest registration first within each.

• A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard ChemotherapyStatus unknownNCT03086291Phase 1
• Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]CompletedNCT03011931Early Phase 1
• Evaluation Of The Portal Pressure By Doppler Ultrasound In Cirrhotic Patients Before And After SimvastatinCompletedNCT02994485Phase 4
• Simvastatin in Overcoming Chemotherapy Resistance in Patients With Relapsed or Refractory Multiple MyelomaWithdrawnNCT02971410Early Phase 1
• Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCAWithdrawnNCT02965911Phase 1/2
• Simvastatin to Prevent SCI-Induced Bone LossStatus unknownNCT02946424Phase 2
• Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-respondersStatus unknownNCT02937012Phase 3
• Randomized Comparative Efficacy and Safety Study of Intermittent Simvastatin and Fenofibrate in HemodialysisCompletedNCT02886299Phase 4
• Effect of Statin Use on Aldosterone SecretionCompletedNCT02871687Phase 1
• Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary CirrhosisCompletedNCT02823353Phase 3
• The DDI Study of SP2086 and SimvastatinStatus unknownNCT02817243Phase 1
• The Drug-drug Interaction of SP2086 and SimvastatinCompletedNCT02815722Phase 1
• Postprandial Fatty Acid Metabolism in the Natural History of Type 2 Diabetes (T2D)CompletedNCT02808182Not applicable
• The Effect of Acipimox on GLP (Glucagon-like Peptide)-1 SecretionCompletedNCT02796950Not applicable
• Increasing Mitochondrial Function on Skeletal Muscle Performance in Older MenCompletedNCT02792621Not applicable
• Simvastatin as a Neuroprotective Treatment for Moderate Parkinson's DiseaseCompletedNCT02787590Phase 2
• Lipolytic Effects of GH in Hypopituitary Patients in VivoCompletedNCT02782208Not applicable
• A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy SubjectsCompletedNCT02770222Phase 1
• Effects of Simvastatin and Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) PatientsStatus unknownNCT02766803Phase 4
• Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan SyndromeCompletedNCT02713945Phase 3
• The Effect of Bezafibrate on Cholestatic ItchStatus unknownNCT02701166Phase 3
• Pharmacokinetic and Safety Study of Cenicriviroc and HMG-CoA Reductase Inhibitors, Caffeine and DigoxinCompletedNCT02685462Phase 1
• A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy SubjectsCompletedNCT02675309Phase 1
• A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mgCompletedNCT02659397Phase 2
• Effect of Gemcabene on the Pharmacokinetics of Simvastatin in Healthy VolunteersCompletedNCT02587390Phase 1
• Drug Interaction Study of MGL-3196 With Rosuvastatin and SimvastatinCompletedNCT02542969Phase 1
• Effect of Simvastatin Withdrawal on Ocular Endothelial FunctionWithdrawnNCT02533141Phase 4
• Renal Hemodynamic Effects of the HMG-CoA Reductase Inhibitors in Normal Volunteers and in Patients With Chronic Renal FailureCompletedNCT02511418Not applicable
• BezafibrateTreatment for Bipolar Depression: A Proof of Concept StudyCompletedNCT02481245Phase 2
• Study to Evaluate the Effects of MBX-8025 in Patients With HoFHCompletedNCT02472535Phase 2
• To Compare the Efficacy and Safety of Carvedilol With or Without Simvastatin in Patients With Portal Hypertension and Esophageal Varices.CompletedNCT02465645Not applicable
• Fenofibrate and Propranolol in Burn PatientsTerminatedNCT02452255Phase 2/3
• Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult SubjectsCompletedNCT02447601Phase 1
• Trial of Simvastatin for the Treatment of Severe AsthmaWithdrawnNCT02433535Phase 2
• Cilostazol-Simvastatin Drug Interaction StudyStatus unknownNCT02431013Phase 1
• Role of Immune Responses After Acute Myocardial InfarctionStatus unknownNCT02428374Phase 4
• CKD-337(2) Drug-drug Interaction StudyCompletedNCT02422030Phase 1
• Trial to Evaluate the Efficacy of Simvastatin for Smoking CessationCompletedNCT02399709Phase 2
• A Study of Bezafibrate in Mitochondrial MyopathyCompletedNCT02398201Phase 2
• Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS TumorsCompletedNCT02390843Phase 1
• Simvastatin and Metformin in Chronic PeriodontitisCompletedNCT02372656Phase 2/3
• Statin DistributionCompletedNCT02360826Phase 1
• Metformin and Simvastatin Use in Bladder CancerStatus unknownNCT02360618Phase 2
• Evaluate the Efficacy of Fenofibrate on MicroalbuminuriaStatus unknownNCT02314533Phase 4
• Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fed ConditionsCompletedNCT02306902Not applicable
• Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fasting ConditionsCompletedNCT02306889Not applicable
• Bezafibrate for Hyperfibrinogenemia in Acute Myocardial InfarctionCompletedNCT02291796Phase 4
• Anti-Platelet and Statin Therapy to Prevent Cancer-Associated ThrombosisCompletedNCT02285738Early Phase 1
• Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed DyslipidemiaCompletedNCT02262143Phase 3
• In Vivo Specificity of KUC 7483 CL Co-administered With Bisoprolol, Propranolol, and Acipimox in Healthy Male SubjectsCompletedNCT02256722Phase 1
• SIMOX - Induction of Oxidative StressCompletedNCT02256254Phase 2
• Use of Simvastatin as a Steroid Sparing Agent for Uveitis PatientsStatus unknownNCT02252328Phase 2/3
• Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin AloneStatus unknownNCT02232360Phase 4
• Pharmacokinetics of Simvastatin and Its Metabolite Simvastatin Acid With and Without Concomitant Administration of Telmisartan in Healthy SubjectsCompletedNCT02187536Phase 1
• Capecitabine Plus Simvastatin in Locally Advanced Rectal Cancer PatientsStatus unknownNCT02161822Phase 2
• Characterization of High Density Lipoprotein (HDL) in Type 2 Diabetes (T2D) After Fenofibrate or Niacin TreatmentCompletedNCT02153879Phase 4
• Simvastatin Effect on Portal HypertensionCompletedNCT02134626Phase 3
• Early Aortic Valve Lipoprotein(a) Lowering TrialWithdrawnNCT02109614Early Phase 1
• Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin TherapyCompletedNCT02072161Phase 2
• Efficacy of Simvastatin for the Treatment of COPDCompletedNCT02070133Phase 3
• Clinical and Economic Outcome of Simvastatin in Critically Ill Septic PatientCompletedNCT02067949Phase 3
• CKD-337 Drug Interaction StudyCompletedNCT02066207Phase 1
• Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer DiseaseCompletedNCT02045056Early Phase 1
• A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer PatientsCompletedNCT02026583Phase 2
• Niacin on Immune Activation : a Proof-of-concept StudyCompletedNCT02018965Phase 2
• Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary SyndromeStatus unknownNCT02015988Phase 4
• Simvastatin Addition for Patients With Recent-onset SchizophreniaCompletedNCT01999309Phase 3
• Effects of Niacin On Fatty Acid TrappingCompletedNCT01984073Phase 1
• Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male VolunteersCompletedNCT01964365Phase 1
• Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With AtorvastatinStatus unknownNCT01956201Phase 3
• A Two-part Study to Investigate the Interaction and Pharmacokinetics of GSK2586184CompletedNCT01953835Phase 1
• Short-term Effect of Extended-release Niacin on Endothelial Function.CompletedNCT01942291Phase 4
• Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic PatientsCompletedNCT01941836Phase 2
• Effects of Fenofibrate on Endothelial Progenitor Cells in DiabetesCompletedNCT01927315Phase 4
• Benefit of Elevation of HDL-C in WomenCompletedNCT01921010Phase 4
• Feeding Trial to Determine How Combinations of Different Dietary Bioactive Ingredients Influence High Density Lipoprotein (HDL) MetabolismCompletedNCT01803594Not applicable
• A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With HypercholesterolemiaCompletedNCT01779453Phase 2
• Efficacy Study of SIMVASTATIN to Treat Chronic Rhinosinusitis After Failure of Optimal TreatmentTerminatedNCT01771198Phase 2
• Evaluation of Pharmacokinetic Interaction Between Micronized Fenofibrate and PitavastatinCompletedNCT01767610Phase 1
• Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of StatinsTerminatedNCT01764451Early Phase 1
• Assess the Pharmacokinetics of Rosuvastatin and Simvastatin When Administered Alone or in Combination With FostamatinibCompletedNCT01725230Phase 1
• Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode PsychosisCompletedNCT01720095Phase 3
• Statin Recapture Therapy Before Coronary Artery Bypass GraftingCompletedNCT01715714Phase 4
• A Pharmacokinetic Interaction Study Between TMC435, Atorvastatin and Simvastatin in Healthy ParticipantsCompletedNCT01689623Phase 1
• ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cARTTerminatedNCT01683656Phase 4
• Vascular and Metabolic Effects of Vytorin vs SimvastatinCompletedNCT01666067Phase 4
• Vascular and Metabolic Effects of Fenofibrate/Omega vs FenofibrateCompletedNCT01666041Phase 4
• Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary CirrhosisCompletedNCT01654731Phase 3
• The Short-term Effects of Simvastatin on the Vision of Males Affected by ChoroideremiaTerminatedNCT01654562Phase 1/2
• Effect of Simvastatin on Pneumonia Prognosis in Elderly PatientsStatus unknownNCT01651728Phase 3
• Study for Identifying Optimal Simvastatin Formulation for Uniform Time to Maximum Plasma ConcentrationTerminatedNCT01642862Phase 1
• A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 DiabetesCompletedNCT01607294Phase 2
• Randomized Double Blind Placebo Control Study in Patients with SchizophreniaCompletedNCT01602029Phase 2
• Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned PatientsTerminatedNCT01574131Phase 4
• Study of Metformin With Simvastatin for Men With Prostate CarcinomaWithdrawnNCT01561482Phase 2
• Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of HIP0901 CapsuleCompletedNCT01555398Phase 1
• A Prevention Trial in Subjects at High Risk for Breast CancerCompletedNCT01500577Phase 2
• A Multiple Ascending Dose Study of ETC-1002 in Healthy SubjectsCompletedNCT01485146Phase 1
• A Study To Estimate The Effect Of Repeated Dosing of PF-05175157 On The Pharmacokinetics Of A Single Dose Of Simvastatin In Healthy Adult SubjectsCompletedNCT01469468Phase 1
• Nicotinic Acid Composition of HDL and Arterial Endothelium Function in Premature Coronary Heart Disease and High HDLTerminatedNCT01450410Phase 4

← Hypolipidemic Agents overview